GTCR and Corza Health Merge Surgical Specialties and TachoSil to Create Corza Medical

Corza Medical (GTCR Portfolio Company) Acquires Katena Products from Audax Private Equity

December 2, 2021

Medical Devices

Corza Medical, a GTCR portfolio company, has acquired Katena Products from Audax Private Equity. Katena is a Parsippany, New Jersey–based manufacturer of precision ophthalmic instruments, single-use devices and specialty biologics with more than 200 employees and sales in over 110 countries. Audax, which acquired Katena in 2015, supported the company's operational and M&A-driven growth during its ownership.

Corza Medical (GTCR Portfolio) Acquires Barron Precision Instruments

June 8, 2022

Medical Devices

GTCR-backed Corza Medical has acquired Barron Precision Instruments (BPI), a founder-owned manufacturer of disposable ophthalmic surgery devices based in Grand Blanc, Michigan. The add-on expands Corza's ophthalmology portfolio and manufacturing footprint, supporting its Corza Ophthalmology business unit and GTCR's continued buildout of the platform.

GTCR Invests in Biocoat

November 2, 2022

Medical Devices

GTCR has made a strategic, majority recapitalization investment in Biocoat Holdings, LLC, a Horsham, Pennsylvania-based provider of biocompatible hydrophilic coatings and dip-coating equipment for medical devices. Existing investor 1315 Capital and Biocoat management retain minority stakes; GTCR will partner with CEO Jim Moran and add industry veteran Chip Hance as Executive Chairman to support growth, capability expansion and follow-on acquisitions.

Solventum Acquires Acera Surgical

December 23, 2025

Medical Devices

Solventum (NYSE: SOLV) has completed the acquisition of Acera Surgical, a privately held bioscience company that develops synthetic tissue matrices for regenerative wound care, for $725 million upfront plus up to $125 million in contingent payments. The deal expands Solventum's MedSurg and advanced wound care portfolio with Acera's synthetic electrospun matrix technology; Acera is expected to generate about $90 million in sales in 2025.

BioVentrix Acquires MateraCor, Inc.

January 27, 2022

Medical Devices

BioVentrix, a privately held medical device company focused on less invasive left-ventricle therapies, has acquired MateraCor, Inc., a Southern California start-up developing an injectable alginate-based hydrogel and delivery system (TCMR) to prevent and reverse heart failure. The deal expands BioVentrix’s product portfolio for left ventricular restoration and adds development expertise as the company builds a platform of complementary heart-failure therapies.

Quasar Medical Acquires Nordson MEDICAL Design & Development Businesses in Galway and Tecate

September 2, 2025

Medical Devices

Quasar Medical has completed the acquisition of Nordson MEDICAL's design & development contract manufacturing businesses in Galway, Ireland and Tecate, Mexico. The deal expands Quasar's global CDMO capabilities, adds nearly 200 employees, and provides FDA-registered, ISO 13485-certified facilities to strengthen design, prototyping and high-volume manufacturing for medical device OEMs.